NCT04874558 - Ultra-low-dose Chest CT for HHT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 21, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hereditary Hemorrhagic Telangiectasia

Interventions

DIAGNOSTIC_TEST

Ultra-low dose chest CT

A novel CT technique with a new dose optimization and efficiency technology and automatic kV selection, which greatly reduces the dose of radiation exposure compared to a standard chest CT.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester